A Prospective, Comparative Study of Quality of Life among Patients with Small Renal Masses Choosing Active Surveillance and Primary Intervention

被引:51
作者
Patel, Hiten D. [1 ,2 ]
Riffon, Mark F. [1 ,2 ]
Joice, Gregory A. [1 ,2 ]
Johnson, Michael H. [1 ,2 ]
Chang, Peter [3 ]
Wagner, Andrew A. [3 ]
McKiernan, James M. [4 ]
Trock, Bruce J. [1 ,2 ]
Allaf, Mohamad E. [1 ,2 ]
Pierorazio, Phillip M. [1 ,2 ]
机构
[1] Johns Hopkins Univ, Sch Med, James Buchanan Brady Urol Inst, Baltimore, MD USA
[2] Johns Hopkins Univ, Sch Med, Dept Urol, Baltimore, MD USA
[3] Beth Israel Deaconess Med Ctr, Div Urol, Boston, MA 02215 USA
[4] Columbia Univ, Med Ctr, Dept Urol, New York, NY USA
关键词
kidney neoplasms; carcinoma; renal cell; watchful waiting; early medical intervention; quality of life; NEPHRON-SPARING SURGERY; T1A KIDNEY CANCER; CELL CARCINOMA; RADICAL NEPHRECTOMY; HEALTH SURVEY; MANAGEMENT; OUTCOMES; TUMORS; SF-12; DIAGNOSIS;
D O I
10.1016/j.juro.2016.04.073
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: To our knowledge quality of life has not been evaluated in rigorous fashion in patients undergoing active surveillance for small renal masses. The prospective, multi-institutional DISSRM (Delayed Intervention and Surveillance for Small Renal Masses) Registry was opened on January 1, 2009, enrolling patients with cT1a (4.0 cm or less) small renal masses who elected primary intervention or active surveillance. Materials and Methods: Patients were enrolled following a choice of active surveillance or primary intervention. The active surveillance protocol includes imaging every 4 to 6 months for 2 years and every 6 to 12 months thereafter. The SF12 (R) quality of life questionnaire was completed at study enrollment, at 6 and 12 months, and annually thereafter. MCS (Mental Component Summary), PCS (Physical Component Summary) and overall score were evaluated among the groups and with time using ANOVA and linear regression mixed modeling. Results: At 82 months among 3 institutions 539 patients were enrolled with a mean +/- SD followup of 1.8 +/- 1.7 years. Of the patients 254 were on active surveillance, 285 were on primary intervention and 21 were on active surveillance but crossed over to delayed intervention. A total of 1,497 questionnaires were completed. Total and PCS quality of life scores were better for primary intervention at enrollment through 5 years. There were generally no differences in MCS scores among the groups and there was a trend of improving scores with time. Conclusions: In a prospective registry of patients undergoing active surveillance or primary intervention for small renal masses those undergoing primary intervention had higher quality of life scores at baseline. This was due to a perceived benefit in the physical health domain, which persisted throughout followup. Mental health, which includes the domains of depression and anxiety, was not adversely affected while on active surveillance, and it improved with time after selecting a management strategy.
引用
收藏
页码:1356 / 1362
页数:7
相关论文
共 50 条
  • [21] Change in Nephrometry Scoring in Small Renal Masses (<4 cm) on Active Surveillance: Preliminary Observations From Tayside Active Surveillance Cohort (TASC) Study
    Mohammed, Khan H.
    Zhang Wanzhe
    Catherine, Paterson
    Magda, Szewczyk-Bieda
    Lang, Stephen
    Ghulam, Nabi
    ACADEMIC RADIOLOGY, 2018, 25 (11) : 1381 - 1387
  • [22] Quality-of-life outcomes in patients with small renal masses
    Matin, Surena F.
    NATURE REVIEWS UROLOGY, 2016, 13 (08) : 443 - 444
  • [23] Charlson score as a single pertinent criterion to select candidates for active surveillance among patients with small renal masses
    Audenet, Francois
    Audouin, Marie
    Drouin, Sarah J.
    Comperat, Eva
    Mozer, Pierre
    Chartier-Kastler, Emmanuel
    Mejean, Arnaud
    Cussenot, Olivier
    Shariat, Shahrokh F.
    Roupret, Morgan
    WORLD JOURNAL OF UROLOGY, 2014, 32 (02) : 513 - 518
  • [24] Active surveillance for small renal masses diagnosed in elderly or comorbid patients: Looking for the best treatment strategy
    Brunocilla, E.
    Borghesi, M.
    Schiavina, R.
    Palmieri, F.
    Pernetti, R.
    Monti, C.
    Martorana, G.
    ACTAS UROLOGICAS ESPANOLAS, 2014, 38 (01): : 1 - 6
  • [25] Active surveillance and focal ablation for small renal masses: a better solution for comorbid patients
    Woskowiak, Piotr
    Lewicka, Katarzyna
    Bureta, Adrianna
    Salagierski, Maciej
    ARCHIVES OF MEDICAL SCIENCE, 2020, 16 (05) : 1111 - 1118
  • [26] Predictors of growth kinetics and outcomes in small renal masses (SRM ≤4 cm in size): Tayside Active Surveillance Cohort (TASC) Study
    Paterson, C.
    Yew-Fung, C.
    Sweeney, C.
    Szewczyk-Bieda, M.
    Lang, S.
    Nabi, G.
    EJSO, 2017, 43 (08): : 1589 - 1597
  • [27] Re: Evaluation of Growth Rates for Small Renal Masses in Elderly Patients Undergoing Active Surveillance
    Alam, R.
    Yerrapragada, A.
    Wlajnitz, T.
    JOURNAL OF UROLOGY, 2023, 210 (05) : 818 - 819
  • [29] Small Renal Masses Initially Managed Using Active Surveillance: Results From a Retrospective Study With Long-Term Follow-Up
    Brunocilla, Eugenio
    Borghesi, Marco
    Schiavina, Riccardo
    Della Mora, Livia
    Dababneh, Hussam
    La Manna, Gaetano
    Monti, Carlo
    Martorana, Giuseppe
    CLINICAL GENITOURINARY CANCER, 2014, 12 (03) : 178 - 181
  • [30] Five-year Analysis of a Multi-institutional Prospective Clinical Trial of Delayed Intervention and Surveillance for Small Renal Masses: The DISSRM Registry
    Pierorazio, Phillip M.
    Johnson, Michael H.
    Ball, Mark W.
    Gorin, Michael A.
    Trock, Bruce J.
    Chang, Peter
    Wagner, Andrew A.
    McKiernan, James M.
    Allaf, Mohamad E.
    EUROPEAN UROLOGY, 2015, 68 (03) : 408 - 415